Immunomic Therapeutics Explains Proprietary LAMP-vax Platform in Nature Advertorial Supplement
March 03, 2015 16:44 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa., and ROCKVILLE, Md., March 3, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics to Present Data on Its Proprietary LAMP Vaccine Platform at 2015 American Academy of Allergy, Asthma and Immunology Meeting
February 20, 2015 09:45 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., Feb. 20, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company with laboratories in Rockville, MD, today announced the...